Analgecine for the Treatment of Neuropathic Pain

Clinical trial NCT02633618 · COMPLETED

Trial details

NCT number: NCT02633618
Sponsor: VanWorld Pharmaceutical (Rugao) Company Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuropathic Pain

Start date: 2005-08-01
Primary completion: 2005-12-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.